VALACICLOVIR TEVA 500 mg, film-coated tablet scored 112 tablets
Active ingredients: Valacyclovir hydrochloride dihydrate, Valacyclovir
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored112 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VALACICLOVIR TEVA 500 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 112 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Apr 2011
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64914777CIP73955975CIP133400939559759Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DIHYDRATÉ DE VALACICLOVIRcomprimé | — | SA |
| VALACICLOVIRcomprimé | 500 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.